(MedPage Today) — This week’s highlights include studies from the European Society of Cardiology, including research on the eyes as windows to potential cardiovascular risk, and dysfunctional coronary artery flow in prediabetics.
Month: August 2012
First Successfull Implantation of Bionic Eye
At Bionic Vision Australia, a consortium of researchers working on an eye prosthesis, the implantation of a bionic eye with 24 electrodes has turned out to be a success. A 54 year old female patient with vision loss due to retinitis pigmentosa had rece…
Useful vision maintained long term after lens-sparing vitrectomy for ROP
Infants treated with lens-sparing vitrectomy for retinopathy of prematurity maintain a level of visual acuity necessary for useful vision into their eighth year of life, study results show.
Cataract Risk for Kids on Kalydeco for Cystic Fibrosis
Children taking Vertex Pharmaceuticals Inc’s cystic fibrosis pill Kalydeco (ivacaftor) may be at risk of getting cataracts, based on a study in juvenile rats. Reuters Health Information
Dry Eye Risk Similar After Laser Vision Surgeries
Two laser surgeries used to correct blurry vision have a similar chance of causing dry eyes, at least temporarily, a new study finds. Reuters Health Information
Risk of cataracts with ivacaftor (Kalydeco) reported in animal studies
Source: Reuters Health News
Area: News
The FDA has highlighted on its website the findings from a study in juvenile rats of the risk of developing cataracts with cystic fibrosis drug ivacaftor (Kalydeco). This information has been added to the label f…
Cardiovascular Events in Diabetic Macular Edema
Why do cardiovascular complications often present in patients with serious eye diseases such as diabetic macular edema? This new study explains the connection. BMC Ophthalmology
Tips for parents to help their kids get a smart start to the academic year
The first day of school always requires preparations — notebooks, pens and a new set of clothes. But don’t forget to prepare for your child’s health, says Dr. Joan Bregstein, a physician in the Division of Pediatric Emergency Medicine at NewYork-Presb…
Lucentis Approved for Diabetic Retinopathy
Lucentis is now FDA approved for the treatment of diabetic retinopathy. While recently approved, this is not really a “new” treatment.
Dry eye risk similar after laser vision surgeries
NEW YORK (Reuters Health) – Two laser surgeries used to correct blurry vision have a similar chance of
causing dry eyes, at least temporarily, a new study finds.
An Infant With Esotropia and a Cataract
What condition do you suspect is present in this 2-month-old girl with esotropia and a dense cataract in 1 eye? Medscape Ophthalmology
Adhesive May Improve Safety Of LASIK Eye Surgery
Kansas State University researchers have developed a glue mixture that may reduce risks after laser vision correction surgery. Stacy Littlechild, a recent bachelor’s degree graduate in biology originally from Wakeeney, is the lead author of two studies…
FDA Grants Orphan Drug Status to Gevokizumab
The FDA has granted orphan drug designation to gevokizumab for the treatment of noninfectious intermediate uveitis, posterior uveitis, or panuveitis, or chronic noninfectious anterior uveitis. Orphan Drug Approvals
Fibrin glue may cause TASS
Fibrin glue might be a potential cause of toxic anterior segment syndrome (TASS).
Allergan, Molecular Partners enter DARPin agreements
Allergan Inc. and Molecular Partners AG have entered into agreements to discover, develop, and
commercialize designed ankyrin repeat protein (DARPin) products.
Retinal disease research gets $2.4 million boost
The Foundation Fighting Blindness is funding projects related to age-related macular degeneration,
retinitis pigmentosa, Leber’s congenital amaurosis, and Usher syndrome.
Gevokizumab receives orphan drug designation
Gevokizumab, a beta modulating antibody from XOMA Corp., has received FDA orphan drug designation for
the treatment of several types of non-infectious uveitis.
Share tips with patients during Cataract Awareness Month
Share these tips with patients during Cataract Awareness Month, courtesy of the American Academy of
Ophthalmology and its EyeSmart program.
Phase II study for travoprost punctum plugs
Ocular Therapeutix Inc. is initiating a phase II clinical trial of OTX-TP2, a 2-month travoprost
punctum plug for treating ocular hypertension and glaucoma.
Laser surgery education gets $1 million boost
Ophthalmologists will have a new way to learn about advances in laser surgery next year, thanks to a
$1 million donation made to the American Academy of Ophthalmology.